Shares of BioPharma Credit PLC (OTCMKTS:BOPCF – Get Free Report) dropped 6.5% during trading on Friday . The stock traded as low as $0.9262 and last traded at $0.9262. 99,452 shares traded hands during trading, a decline of 71% from the average session volume of 337,758 shares. The stock had previously closed at $0.9903.
BioPharma Credit Stock Performance
The stock’s 50 day simple moving average is $0.97 and its two-hundred day simple moving average is $0.94.
About BioPharma Credit
BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.
Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.
Further Reading
- Five stocks we like better than BioPharma Credit
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
